Janssen Presents Longer-Term Talquetamab Follow-Up Data
Additional long-term data from the TRiMM-2 study in patients receiving talquetamab and DARZALEX® (daratumumab) subcutaneous (SC) formulation combination...
United States Castillay Leóp Region Flamande Talquetamab Monotherapy Maria Victoria Mateos Edmond Chan
Source: globenewswire.com